Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors

Citation
Sachinidis A, Nikolic D, Stoian AP, et al. Metabolism 2020; epub ahead of press.